Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1987 4
1988 1
1989 1
1990 1
1991 2
1992 4
1993 1
1994 3
1995 1
1996 3
1997 3
1998 1
1999 3
2000 2
2001 2
2002 6
2003 3
2004 4
2005 2
2006 4
2007 3
2008 5
2009 5
2010 3
2011 7
2012 8
2013 7
2014 8
2015 13
2016 16
2017 11
2018 6
2019 4
2020 7
2021 10
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Results by year
Filters applied: . Clear all
Page 1
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
Mackinnon AC, Gibbons MA, Farnworth SL, Leffler H, Nilsson UJ, Delaine T, Simpson AJ, Forbes SJ, Hirani N, Gauldie J, Sethi T. Mackinnon AC, et al. Among authors: sethi t. Am J Respir Crit Care Med. 2012 Mar 1;185(5):537-46. doi: 10.1164/rccm.201106-0965OC. Epub 2011 Nov 17. Am J Respir Crit Care Med. 2012. PMID: 22095546 Free PMC article.
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.
Hirani N, MacKinnon AC, Nicol L, Ford P, Schambye H, Pedersen A, Nilsson UJ, Leffler H, Sethi T, Tantawi S, Gravelle L, Slack RJ, Mills R, Karmakar U, Humphries D, Zetterberg F, Keeling L, Paul L, Molyneaux PL, Li F, Funston W, Forrest IA, Simpson AJ, Gibbons MA, Maher TM. Hirani N, et al. Among authors: sethi t. Eur Respir J. 2021 May 27;57(5):2002559. doi: 10.1183/13993003.02559-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33214209 Free PMC article. Clinical Trial.
An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade.
Vuong L, Kouverianou E, Rooney CM, McHugh BJ, Howie SEM, Gregory CD, Forbes SJ, Henderson NC, Zetterberg FR, Nilsson UJ, Leffler H, Ford P, Pedersen A, Gravelle L, Tantawi S, Schambye H, Sethi T, MacKinnon AC. Vuong L, et al. Among authors: sethi t. Cancer Res. 2019 Apr 1;79(7):1480-1492. doi: 10.1158/0008-5472.CAN-18-2244. Epub 2019 Jan 23. Cancer Res. 2019. PMID: 30674531
CD98 signals controlling tumorigenesis.
Ip H, Sethi T. Ip H, et al. Among authors: sethi t. Int J Biochem Cell Biol. 2016 Dec;81(Pt A):148-150. doi: 10.1016/j.biocel.2016.11.005. Epub 2016 Nov 10. Int J Biochem Cell Biol. 2016. PMID: 27840151 Review.
Radon and lung cancer.
Sethi TK, El-Ghamry MN, Kloecker GH. Sethi TK, et al. Clin Adv Hematol Oncol. 2012 Mar;10(3):157-64. Clin Adv Hematol Oncol. 2012. PMID: 22402423 Review.
Lung cancer stem cells-characteristics, phenotype.
Hardavella G, George R, Sethi T. Hardavella G, et al. Among authors: sethi t. Transl Lung Cancer Res. 2016 Jun;5(3):272-9. doi: 10.21037/tlcr.2016.02.01. Transl Lung Cancer Res. 2016. PMID: 27413709 Free PMC article. Review.
Probiotics in pediatric care.
Sethi T. Sethi T. Explore (NY). 2009 Jul-Aug;5(4):245-9. doi: 10.1016/j.explore.2009.05.008. Explore (NY). 2009. PMID: 19608114 Review. No abstract available.
Lung cancer. Introduction.
Sethi T. Sethi T. Thorax. 2002 Nov;57(11):992-3. doi: 10.1136/thorax.57.11.992. Thorax. 2002. PMID: 12403885 Free PMC article. Review.
Chemotherapy Knowledge Base Management in the Era of Precision Oncology.
Rubinstein SM, Sethi T, Venepalli NK, Gyawali B, Schwartz C, Rivera DR, Yang PC, Warner JL. Rubinstein SM, et al. Among authors: sethi t. JCO Clin Cancer Inform. 2021 Jan;5:30-35. doi: 10.1200/CCI.20.00076. JCO Clin Cancer Inform. 2021. PMID: 33411619 Free PMC article.
169 results